Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of Hibbett, Inc. HIBB rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.

Hibbett shares jumped 18.4% to $85.83 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Pineapple Energy Inc. PEGY shares gained 38% to $0.0632 in pre-market trading after falling 10% on Monday
  • ImmunityBio, Inc. IBRX gained 34.6% to $6.65 in pre-market trading after the company received FDA approval for ANKTIVA, a first-in-class IL-15 receptor agonist, for BCG-unresponsive non-muscle invasive bladder cancer.
  • Nuwellis, Inc. NUWE gained 31.5% to $0.43 in pre-market trading after the company received a notice of allowance for its U.S. patent application 18/463,612 titled “Venous Blood Flow Stimulator For Extracorporeal Therapy”
  • AGBA Group Holding Limited AGBA climbed 24% to $3.10 in pre-market trading on continued upward momentum after the company on Friday announced it entered into a definitive merger agreement with Triller.
  • HWH International Inc. HWH rose 15.5% to $1.48 in today's pre-market trading after declining 3% on Monday.
  • Theriva Biologics, Inc. TOVX gained 15.5% to $0.4748 in pre-market trading after the company announced it will present preclinical data for the potential synergy of VCN-01 and first-line pancreatic cancer chemotherapy regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting.
  • Azitra, Inc. AZTR shares gained 13.5% to $0.2216 in pre-market trading after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.
  • China Natural Resources, Inc. CHNR shares gained 12% to $1.12 in pre-market trading.
  • Cidara Therapeutics, Inc. CDTX shares rose 11.9% to $0.5750 in pre-market trading following upbeat quarterly results.

Losers

  • Abeona Therapeutics Inc. ABEO fell 48.1% to $3.82 in pre-market trading after the company announced the FDA issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.
  • Greenwave Technology Solutions, Inc. GWAV fell 31.1% to $0.0870 in pre-market trading after gaining over 8% on Monday.
  • T2 Biosystems, Inc. TTOO declined 18.7% to $2.57 in pre-market trading after gaining around 7% on Monday.
  • Phio Pharmaceuticals Corp. PHIO fell 16.8% to $0.69 in pre-market trading. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.
  • Calix, Inc. CALX shares fell 16.8% to $24.60 in pre-market trading after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.
  • Complete Solaria, Inc. CSLR fell 13.7% to $0.3360 in pre-market trading after dipping around 14% on Monday.
  • Tungray Technologies Inc. TRSG shares declined 13.7% to $6.37 in pre-market trading after gaining 24% on Monday.
  • Jaguar Health, Inc. JAGX shares fell 12.1% to $0.1581 in pre-market trading after the company filed for a mixed shelf offering of up to $75 million.
  • YY Group Holding Limited YYGH fell 13.8% to $2.50 pre-market trading after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.
  • Cadence Design Systems, Inc. CDNS fell 5.7% to $268.91 pre-market trading after the company issued second-quarter guidance below estimates.

Now Read This: General Motors, Tesla And 3 Stocks To Watch Heading Into Tuesday

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsMoversLosersPremarket Movers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!